Transcatheter closure of the left atrial appendage: Initial experience with the amplatzer cardiac plug device

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 2, 2010, Pages 186-192

  Rodés Cabau, Josep ^a   Champagne, Jean ^a   Bernier, Mathieu ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Amplatzer cardiac plug; Atrial fibrillation; Left atrial appendage

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

AGED; ARTICLE; BLEEDING; CASE REPORT; DEVICE; DRUG CONTRAINDICATION; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT ATRIUM; HEMARTHROSIS; HUMAN; RETROPERITONEAL HEMATOMA;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; FEMALE; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HUMANS; PROSTHESIS DESIGN; RISK ASSESSMENT; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME; WARFARIN;

EID: 77955139218     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22499     Document Type: Article

References (9)

1. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multicenter feasibility trials. J Am Coll Cardiol 2005;46:9-14.
2. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy. 5-year results of the PLAATO (Percutaneous Left Atrial AppendageTranscatheter Occlusion) Study. JACC Cardiovasc Interv 2009;2:594-600.
3. Ussia GP, Mule M, Cammalleri V, Scarabelli M, Barbanti M, Immè S, Mangiafico S, Marchese A, Galassi AR, Tamburino C. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation. Catheter Cardiovasc Interv 2009;74:217-222.
4. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007; 49:1490-1495. (Pubitemid 46505070)
5. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009;374:534-542.
6. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
7. Stoddard MF, Dawkins PR, Price CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-459.
8. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-46.
9. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003;60:417-422. (Pubitemid 37356515)